Login
Home / 600329.SS : SHH
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

¥34.12 -$12.06 (-26.12%)
SHH · 15 Sep 2026 06:56 UTC
Previous Close
¥34.63
Day Range
¥34¥34.6
Year Range
¥34¥50.95
Market Cap
19.45B
AVG Volume
3.8M
Trailing/Forward PE
30.95/22.16
PEG ratio
2.07
Dividend Yield
14.04%
Next Earnings Date
-
Primary Exchange
Shanghai Stock ExchangeCN
Revenue (CNY)
01B2B3B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (CNY)
-500M0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (CNY)
-500M0500M1B1.5B2B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (CNY)
0200M400M600M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (CNY)
-250M0250M500M750M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (CNY)
-1012324 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (CNY)
0200M400M600M800MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (CNY)
02B4B6BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-6-4-2024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%80%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-5%0%5%10%15%20%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (CNY)
0123Jul 18Jul 19Jun 20Jun 21Jun 22Jun 23Jul 24Jul 25Feb 26Jul 26
Book Value Per Share (CNY)
05101524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (CNY)
05B10B15B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
0102030med 13.01Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
0%2%4%6%med 3.08%Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Sales
2468med 5.33Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
EV/EBITDA
2025303540med 26.14Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
020406080med 29.55Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Price to Book
2.533.544.55med 3.83Dec 24Apr 25Jul 25Oct 25Feb 26Jun 26Sep 26
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
600329.SS
Stockpicker

Video analysis: 600329.SS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.